Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 369.26 USD 4.48% Market Closed
Market Cap: 11.4B USD
Have any thoughts about
Medpace Holdings Inc?
Write Note

Medpace Holdings Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medpace Holdings Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medpace Holdings Inc
NASDAQ:MEDP
Cost of Revenue
-$1.5B
CAGR 3-Years
-24%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$8.6B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-10%

See Also

What is Medpace Holdings Inc's Cost of Revenue?
Cost of Revenue
-1.5B USD

Based on the financial report for Sep 30, 2024, Medpace Holdings Inc's Cost of Revenue amounts to -1.5B USD.

What is Medpace Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%

Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Medpace Holdings Inc have been -24% over the past three years , -20% over the past five years .

Back to Top